[1]
|
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS ARG-28; GLN-28; GLN-32 AND SER-736.
DOI=10.1007/BF00211644; PubMed=2249879 [NCBI, ExPASy, EBI, Israel, Japan]
Davrinche C.,
Abbal M.,
Clerc A.;
"Molecular characterization of human complement factor B subtypes.";
Immunogenetics 32:309-312(1990).
|
[2]
|
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS ARG-28 AND GLN-32.
TISSUE=Liver;
DOI=10.1016/0198-8859(94)90100-7; PubMed=8181962 [NCBI, ExPASy, EBI, Israel, Japan]
Mejia J.E.,
Jahn I.,
de la Salle H.,
Hauptmann G.;
"Human factor B. Complete cDNA sequence of the BF*S allele.";
Hum. Immunol. 39:49-53(1994).
|
[3]
|
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS ARG-28 AND GLN-32.
TISSUE=Liver;
PubMed=8225386 [NCBI, ExPASy, EBI, Israel, Japan]
Schwaeble W.,
Luettig B.,
Sokolowski T.,
Estaller C.,
Weiss E.H.,
Meyer Zum Bueschenfelde K.-H.,
Whaley K.,
Dippold W.;
"Human complement factor B: functional properties of a recombinant zymogen of the alternative activation pathway convertase.";
Immunobiology 188:221-232(1993).
|
[4]
|
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS ARG-28 AND GLN-32.
DOI=10.1016/0161-5890(93)90450-P; PubMed=8247029 [NCBI, ExPASy, EBI, Israel, Japan]
Horiuchi T.,
Kim S.,
Matsumoto M.,
Watanabe I.,
Fujita S.,
Volanakis J.E.;
"Human complement factor B: cDNA cloning, nucleotide sequencing, phenotypic conversion by site-directed mutagenesis and expression.";
Mol. Immunol. 30:1587-1592(1993).
|
[5]
|
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
Jaatinen T.,
Kanerva J.,
Poutanen K.E.,
Saarinen-Pihkala U.,
Lokki M.-L.;
"Expression and alternative splicing of human factor B gene in leukemic mononuclear cells.";
Submitted (FEB-2001) to the EMBL/GenBank/DDBJ databases.
|
[6]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
DOI=10.1101/gr.1736803; PubMed=14656967 [NCBI, ExPASy, EBI, Israel, Japan]
Xie T.,
Rowen L.,
Aguado B.,
Ahearn M.E.,
Madan A.,
Qin S.,
Campbell R.D.,
Hood L.;
"Analysis of the gene-dense major histocompatibility complex class III region and its comparison to mouse.";
Genome Res. 13:2621-2636(2003).
|
[7]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS HIS-9; GLN-32; TRP-32; SER-252; GLU-565 AND GLU-651.
SeattleSNPs program for genomic applications;
Submitted (NOV-2002) to the EMBL/GenBank/DDBJ databases.
|
[8]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
DOI=10.1038/nature02055; PubMed=14574404 [NCBI, ExPASy, EBI, Israel, Japan]
Mungall A.J.,
Palmer S.A.,
Sims S.K.,
Edwards C.A.,
Ashurst J.L.,
Wilming L.,
Jones M.C.,
Horton R.,
Hunt S.E.,
Scott C.E.,
Gilbert J.G.R.,
Clamp M.E.,
Bethel G.,
Milne S.,
Ainscough R.,
Almeida J.P.,
Ambrose K.D.,
Andrews T.D.,
Ashwell R.I.S.,
Babbage A.K.,
Bagguley C.L.,
Bailey J.,
Banerjee R.,
Barker D.J.,
Barlow K.F.,
Bates K.,
Beare D.M.,
Beasley H.,
Beasley O.,
Bird C.P.,
Blakey S.E.,
Bray-Allen S.,
Brook J.,
Brown A.J.,
Brown J.Y.,
Burford D.C.,
Burrill W.,
Burton J.,
Carder C.,
Carter N.P.,
Chapman J.C.,
Clark S.Y.,
Clark G.,
Clee C.M.,
Clegg S.,
Cobley V.,
Collier R.E.,
Collins J.E.,
Colman L.K.,
Corby N.R.,
Coville G.J.,
Culley K.M.,
Dhami P.,
Davies J.,
Dunn M.,
Earthrowl M.E.,
Ellington A.E.,
Evans K.A.,
Faulkner L.,
Francis M.D.,
Frankish A.,
Frankland J.,
French L.,
Garner P.,
Garnett J.,
Ghori M.J.,
Gilby L.M.,
Gillson C.J.,
Glithero R.J.,
Grafham D.V.,
Grant M.,
Gribble S.,
Griffiths C.,
Griffiths M.N.D.,
Hall R.,
Halls K.S.,
Hammond S.,
Harley J.L.,
Hart E.A.,
Heath P.D.,
Heathcott R.,
Holmes S.J.,
Howden P.J.,
Howe K.L.,
Howell G.R.,
Huckle E.,
Humphray S.J.,
Humphries M.D.,
Hunt A.R.,
Johnson C.M.,
Joy A.A.,
Kay M.,
Keenan S.J.,
Kimberley A.M.,
King A.,
Laird G.K.,
Langford C.,
Lawlor S.,
Leongamornlert D.A.,
Leversha M.,
Lloyd C.R.,
Lloyd D.M.,
Loveland J.E.,
Lovell J.,
Martin S.,
Mashreghi-Mohammadi M.,
Maslen G.L.,
Matthews L.,
McCann O.T.,
McLaren S.J.,
McLay K.,
McMurray A.,
Moore M.J.F.,
Mullikin J.C.,
Niblett D.,
Nickerson T.,
Novik K.L.,
Oliver K.,
Overton-Larty E.K.,
Parker A.,
Patel R.,
Pearce A.V.,
Peck A.I.,
Phillimore B.J.C.T.,
Phillips S.,
Plumb R.W.,
Porter K.M.,
Ramsey Y.,
Ranby S.A.,
Rice C.M.,
Ross M.T.,
Searle S.M.,
Sehra H.K.,
Sheridan E.,
Skuce C.D.,
Smith S.,
Smith M.,
Spraggon L.,
Squares S.L.,
Steward C.A.,
Sycamore N.,
Tamlyn-Hall G.,
Tester J.,
Theaker A.J.,
Thomas D.W.,
Thorpe A.,
Tracey A.,
Tromans A.,
Tubby B.,
Wall M.,
Wallis J.M.,
West A.P.,
White S.S.,
Whitehead S.L.,
Whittaker H.,
Wild A.,
Willey D.J.,
Wilmer T.E.,
Wood J.M.,
Wray P.W.,
Wyatt J.C.,
Young L.,
Younger R.M.,
Bentley D.R.,
Coulson A.,
Durbin R.M.,
Hubbard T.,
Sulston J.E.,
Dunham I.,
Rogers J.,
Beck S.;
"The DNA sequence and analysis of human chromosome 6.";
Nature 425:805-811(2003).
|
[9]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT TRP-32.
TISSUE=Colon;
DOI=10.1101/gr.2596504; PubMed=15489334 [NCBI, ExPASy, EBI, Israel, Japan] The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
|
[10]
|
PROTEIN SEQUENCE OF 26-764, PARTIAL NUCLEOTIDE SEQUENCE [MRNA], AND GLYCOSYLATION AT ASN-122; ASN-142; ASN-285 AND ASN-378.
PubMed=6546754 [NCBI, ExPASy, EBI, Israel, Japan]
Mole J.E.,
Anderson J.K.,
Davison E.A.,
Woods D.E.;
"Complete primary structure for the zymogen of human complement factor B.";
J. Biol. Chem. 259:3407-3412(1984).
|
[11]
|
PROTEIN SEQUENCE OF 260-764.
PubMed=6342610 [NCBI, ExPASy, EBI, Israel, Japan]
Christie D.L.,
Gagnon J.;
"Amino acid sequence of the Bb fragment from complement Factor B. Sequence of the major cyanogen bromide-cleavage peptide (CB-II) and completion of the sequence of the Bb fragment.";
Biochem. J. 209:61-70(1983).
|
[12]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] OF 339-764.
PubMed=6308626 [NCBI, ExPASy, EBI, Israel, Japan]
Campbell R.D.,
Porter R.R.;
"Molecular cloning and characterization of the gene coding for human complement protein factor B.";
Proc. Natl. Acad. Sci. U.S.A. 80:4464-4468(1983).
|
[13]
|
NUCLEOTIDE SEQUENCE [MRNA] OF 467-595 AND 752-764.
PubMed=6957884 [NCBI, ExPASy, EBI, Israel, Japan]
Woods D.E.,
Markham A.F.,
Ricker A.T.,
Goldberger G.,
Colten H.R.;
"Isolation of cDNA clones for the human complement protein factor B, a class III major histocompatibility complex gene product.";
Proc. Natl. Acad. Sci. U.S.A. 79:5661-5665(1982).
|
[14]
|
NUCLEOTIDE SEQUENCE [MRNA] OF 16-259.
PubMed=6323161 [NCBI, ExPASy, EBI, Israel, Japan]
Morley B.J.,
Campbell R.D.;
"Internal homologies of the Ba fragment from human complement component Factor B, a class III MHC antigen.";
EMBO J. 3:153-157(1984).
|
[15]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-99.
TISSUE=Blood;
DOI=10.1016/0092-8674(87)90436-3; PubMed=3643061 [NCBI, ExPASy, EBI, Israel, Japan]
Wu L.C.,
Morley B.J.,
Campbell R.D.;
"Cell-specific expression of the human complement protein factor B gene: evidence for the role of two distinct 5'-flanking elements.";
Cell 48:331-342(1987).
|
[16]
|
GLYCATION AT LYS-291.
PubMed=2006911 [NCBI, ExPASy, EBI, Israel, Japan]
Niemann M.A.,
Bhown A.S.,
Miller E.J.;
"The principal site of glycation of human complement factor B.";
Biochem. J. 274:473-480(1991).
|
[17]
|
GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-122; ASN-285 AND ASN-378, AND MASS SPECTROMETRY.
TISSUE=Plasma;
DOI=10.1021/pr0502065; PubMed=16335952 [NCBI, ExPASy, EBI, Israel, Japan]
Liu T.,
Qian W.-J.,
Gritsenko M.A.,
Camp D.G. II,
Monroe M.E.,
Moore R.J.,
Smith R.D.;
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.";
J. Proteome Res. 4:2070-2080(2005).
|
[18]
|
X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 467-764.
DOI=10.1093/emboj/19.2.164; PubMed=10637221 [NCBI, ExPASy, EBI, Israel, Japan]
Jing H.,
Xu Y.,
Carson M.,
Moore D.,
Macon K.J.,
Volanakis J.E.,
Narayana S.V.L.;
"New structural motifs on the chymotrypsin fold and their potential roles in complement factor B.";
EMBO J. 19:164-173(2000).
|
[19]
|
VARIANTS HIS-9 AND GLN-32, AND INVOLVEMENT IN REDUCED RISK OF ARMD.
DOI=10.1038/ng1750; PubMed=16518403 [NCBI, ExPASy, EBI, Israel, Japan]
Gold B.,
Merriam J.E.,
Zernant J.,
Hancox L.S.,
Taiber A.J.,
Gehrs K.,
Cramer K.,
Neel J.,
Bergeron J.,
Barile G.R.,
Smith R.T.,
Hageman G.S.,
Dean M.,
Allikmets R.;
"Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration.";
Nat. Genet. 38:458-462(2006).
|
|